Grifols SA - ADR - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 1.83475
Author: Trendlyne DVM scores

about

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once i...

8.44 0.08 (0.96%)

36.35% Gain from 52W Low

1.3M

XNAS Volume

High vol. this week

XNAS 07 Nov, 2025 4:00 PM (EST)

Board Meeting

The board meeting for Grifols SA - ADR - Level III is scheduled for today, for the purpose of Grifols SA Third Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

28.5 / 100

Technically Neutral

44.9 / 100

1Yr Price target upside is 48%

2 analysts

Grifols SA ADR Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..